Decision-making in the diagnosis of tuberculous meningitis
- PMID: 32964134
- PMCID: PMC7490569
- DOI: 10.12688/wellcomeopenres.15611.1
Decision-making in the diagnosis of tuberculous meningitis
Abstract
Tuberculous meningitis (TBM) is the most devastating form of tuberculosis (TB) but diagnosis is difficult and delays in initiating therapy increase mortality. All currently available tests are imperfect; culture of Mycobacterium tuberculosis from the cerebrospinal fluid (CSF) is considered the most accurate test but is often negative, even when disease is present, and takes too long to be useful for immediate decision making. Rapid tests that are frequently used are conventional Ziehl-Neelsen staining and nucleic acid amplification tests such as Xpert MTB/RIF and Xpert MTB/RIF Ultra. While positive results will often confirm the diagnosis, negative tests frequently provide insufficient evidence to withhold therapy. The conventional diagnostic approach is to determine the probability of TBM using experience and intuition, based on prevalence of TB, history, examination, analysis of basic blood and CSF parameters, imaging, and rapid test results. Treatment decisions may therefore be both variable and inaccurate, depend on the experience of the clinician, and requests for tests may be inappropriate. In this article we discuss the use of Bayes' theorem and the threshold model of decision making as ways to improve testing and treatment decisions in TBM. Bayes' theorem describes the process of converting the pre-test probability of disease to the post-test probability based on test results and the threshold model guides clinicians to make rational test and treatment decisions. We discuss the advantages and limitations of using these methods and suggest that new diagnostic strategies should ultimately be tested in randomised trials.
Keywords: Tuberculosis Meningitis Diagnosis Threshold Decision.
Copyright: © 2020 Boyles TH et al.
Conflict of interest statement
No competing interests were disclosed.
Figures




Similar articles
-
Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid.J Infect. 2017 Aug;75(2):125-131. doi: 10.1016/j.jinf.2017.04.010. Epub 2017 May 10. J Infect. 2017. PMID: 28501491
-
Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis.J Clin Microbiol. 2014 Jan;52(1):226-33. doi: 10.1128/JCM.01834-13. Epub 2013 Nov 6. J Clin Microbiol. 2014. PMID: 24197880 Free PMC article.
-
Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.J Clin Microbiol. 2019 Jul 26;57(8):e00652-19. doi: 10.1128/JCM.00652-19. Print 2019 Aug. J Clin Microbiol. 2019. PMID: 31189584 Free PMC article.
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013359. doi: 10.1002/14651858.CD013359.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Sep 6;9:CD013359. doi: 10.1002/14651858.CD013359.pub3. PMID: 32853411 Free PMC article. Updated.
-
Diagnostic accuracy of Xpert MTB/RIF for tuberculous meningitis: systematic review and meta-analysis.Trop Med Int Health. 2021 Feb;26(2):122-132. doi: 10.1111/tmi.13525. Epub 2020 Nov 30. Trop Med Int Health. 2021. PMID: 33164243 Free PMC article.
Cited by
-
Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia.Emerg Infect Dis. 2022 Mar;28(3):660-671. doi: 10.3201/eid2803.212230. Emerg Infect Dis. 2022. PMID: 35202524 Free PMC article.
-
Treatment outcomes and risk factors of death in childhood tuberculous meningitis in Kandahar, Afghanistan: a prospective observational cohort study.Trans R Soc Trop Med Hyg. 2022 Dec 2;116(12):1181-1190. doi: 10.1093/trstmh/trac066. Trans R Soc Trop Med Hyg. 2022. PMID: 35902999 Free PMC article.
-
Advancing the chemotherapy of tuberculous meningitis: a consensus view.Lancet Infect Dis. 2025 Jan;25(1):e47-e58. doi: 10.1016/S1473-3099(24)00512-7. Epub 2024 Sep 26. Lancet Infect Dis. 2025. PMID: 39342951 Free PMC article.
-
Decision threshold models in medical decision making: a scoping literature review.BMC Med Inform Decis Mak. 2024 Sep 27;24(1):273. doi: 10.1186/s12911-024-02681-2. BMC Med Inform Decis Mak. 2024. PMID: 39334341 Free PMC article.
-
Risk factors for poor outcome in childhood tuberculous meningitis.Sci Rep. 2021 Apr 21;11(1):8654. doi: 10.1038/s41598-021-87082-5. Sci Rep. 2021. PMID: 33883576 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources